Leaflet RINOFUG 0.1% nasal solution


Indicated for: nasal or conjunctival congestion

Substance: naphazoline (adrenergic decongestant)

ATC: R01AA08 (Respiratory system | Decongestants and other nasal preparations for topical use | Sympathomimetics, plain)

Naphazolinum is a nasal decongestant used to relieve nasal congestion associated with colds, sinusitis, or allergic rhinitis. It works by constricting blood vessels in the nasal mucosa, reducing inflammation and congestion.

The medication is available as nasal drops or spray and provides rapid symptom relief. However, long-term use may lead to adverse effects such as rebound congestion (rhinitis medicamentosa).

Side effects may include dryness of the nasal mucosa, burning sensation, or local irritation. It is important not to exceed the recommended duration of use, typically 3-5 days.

Consult your doctor before use, especially if you have cardiovascular conditions, high blood pressure, or other health issues. Use Naphazolinum as directed to avoid complications.

General data about RINOFUG 0.1%

  • Substance: naphazoline
  • Date of last drug list: 01-07-2013
  • Commercial code: W07363001
  • Concentration: 0.1%
  • Pharmaceutical form: nasal solution
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

  • Manufacturer: MEDUMAN S.A. - ROMANIA
  • Holder: MEDUMAN S.A. - ROMANIA
  • Number: 12292/2019/01
  • Shelf life: 3 years-after packing for marketing;after the first opening-30 days

Pharmaceutical forms available for naphazoline

Concentrations available for naphazoline

  • 0.0125
  • 0.03%
  • 0.05%
  • 0.1%
  • 0.3mg/ml